EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • August 13th, 2021 • Scopus BioPharma Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 13th, 2021 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made and entered into as of the 25th day of June, 2021 (the “Effective Date”) by and Olimmune, Inc., a Delaware corporation having its principal place of business at 1021 N Everett St, Glendale, CA 91207 (“Licensee”), and City of Hope, a California nonprofit public benefit corporation located at 1500 East Duarte Road, Duarte, California 91010 (“City of Hope” or “COH”). Licensee and COH are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • August 13th, 2021 • Scopus BioPharma Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 13th, 2021 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made and entered into as of the 25 day of June, 2021 (the “Effective Date”) by and Olimmune, Inc., a Delaware corporation having its principal place of business at 1021 N Everett St, Glendale, CA 91207 (“Licensee”), and City of Hope, a California nonprofit public benefit corporation located at 1500 East Duarte Road, Duarte, California 91010 (“City of Hope” or “COH”). Licensee and COH are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.”